| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antiretroviral chemoprophylaxis: PROUD and pragmatism
|
Mayer, Kenneth H
|
|
2016
|
387 |
10013 |
p. 6-7
2 p.
|
artikel
|
| 2 |
Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data
|
Khatib, Rasha
|
|
2016
|
387 |
10013 |
p. 61-69
9 p.
|
artikel
|
| 3 |
Biomedical research in the USA: at the dawn of a golden age?
|
The Lancet,
|
|
2016
|
387 |
10013 |
p. 1-
1 p.
|
artikel
|
| 4 |
Care of the dying adult: a time for hope
|
The Lancet,
|
|
2016
|
387 |
10013 |
p. 2-
1 p.
|
artikel
|
| 5 |
Coca-Cola's multifaceted threat to global public health
|
Flynn, Andrew
|
|
2016
|
387 |
10013 |
p. 25-
1 p.
|
artikel
|
| 6 |
Current concepts in management of pain in children in the emergency department
|
Krauss, Baruch S
|
|
2016
|
387 |
10013 |
p. 83-92
10 p.
|
artikel
|
| 7 |
Department of Error
|
|
|
2016
|
387 |
10013 |
p. 30-
1 p.
|
artikel
|
| 8 |
Dupilumab: a milestone in the treatment of atopic dermatitis
|
Tsianakas, Athanasios
|
|
2016
|
387 |
10013 |
p. 4-5
2 p.
|
artikel
|
| 9 |
Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial
|
Thaçi, Diamant
|
|
2016
|
387 |
10013 |
p. 40-52
13 p.
|
artikel
|
| 10 |
Everyone counts—so count everyone in England and Wales
|
Bird, Sheila M
|
|
2016
|
387 |
10013 |
p. 25-26
2 p.
|
artikel
|
| 11 |
Health benefits of a carbon tax
|
Cuevas, Soledad
|
|
2016
|
387 |
10013 |
p. 7-9
3 p.
|
artikel
|
| 12 |
Healthy planet, healthy people
|
Beaglehole, Robert
|
|
2016
|
387 |
10013 |
p. 18-
1 p.
|
artikel
|
| 13 |
HIV treatment: time to lean forward
|
Granich, Reuben
|
|
2016
|
387 |
10013 |
p. 27-
1 p.
|
artikel
|
| 14 |
In the novelist's chair
|
Wessely, Simon
|
|
2016
|
387 |
10013 |
p. 19-20
2 p.
|
artikel
|
| 15 |
Iran, sanctions, and research collaborations
|
Rezaee-Zavareh, Mohammad Saeid
|
|
2016
|
387 |
10013 |
p. 28-29
2 p.
|
artikel
|
| 16 |
Iran's health-care system in transition
|
Heshmati, Bahram
|
|
2016
|
387 |
10013 |
p. 29-30
2 p.
|
artikel
|
| 17 |
Italy, the Land of Holy Miracles—revisited
|
Remuzzi, Giuseppe
|
|
2016
|
387 |
10013 |
p. 11-12
2 p.
|
artikel
|
| 18 |
Magdi Yacoub: a lifelong affair with the heart
|
Watts, Geoff
|
|
2016
|
387 |
10013 |
p. 21-
1 p.
|
artikel
|
| 19 |
Magnesium stent scaffolds: DREAMS become reality
|
Lafont, Antoine
|
|
2016
|
387 |
10013 |
p. 3-4
2 p.
|
artikel
|
| 20 |
Mr Laurel, Mr Hardy, and the price of success
|
Yawar, Athar
|
|
2016
|
387 |
10013 |
p. 22-23
2 p.
|
artikel
|
| 21 |
Naeem Aon Jafarey
|
Watts, Geoff
|
|
2016
|
387 |
10013 |
p. 24-
1 p.
|
artikel
|
| 22 |
Nepal's silent epidemic of suicide
|
Cousins, Sophie
|
|
2016
|
387 |
10013 |
p. 16-17
2 p.
|
artikel
|
| 23 |
Offline: Japan's daring gamble in an age of apprehension
|
Horton, Richard
|
|
2016
|
387 |
10013 |
p. 13-
1 p.
|
artikel
|
| 24 |
Physician turned physicist
|
Robinson, Andrew
|
|
2016
|
387 |
10013 |
p. 20-
1 p.
|
artikel
|
| 25 |
Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial
|
McCormack, Sheena
|
|
2016
|
387 |
10013 |
p. 53-60
8 p.
|
artikel
|
| 26 |
Prostate cancer
|
Attard, Gerhardt
|
|
2016
|
387 |
10013 |
p. 70-82
13 p.
|
artikel
|
| 27 |
Rights of refugees—collaboration is key
|
The Lancet,
|
|
2016
|
387 |
10013 |
p. 2-
1 p.
|
artikel
|
| 28 |
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial
|
Haude, Michael
|
|
2016
|
387 |
10013 |
p. 31-39
9 p.
|
artikel
|
| 29 |
Safe water, sanitation, hygiene, and a cholera vaccine
|
Azman, Andrew S
|
|
2016
|
387 |
10013 |
p. 28-
1 p.
|
artikel
|
| 30 |
Suicide in Iran
|
Mirhashemi, Sedigheh
|
|
2016
|
387 |
10013 |
p. 29-
1 p.
|
artikel
|
| 31 |
Uncounted causes of death
|
Byass, Peter
|
|
2016
|
387 |
10013 |
p. 26-27
2 p.
|
artikel
|
| 32 |
Universal access to medicines
|
Niessen, Louis W
|
|
2016
|
387 |
10013 |
p. 9-11
3 p.
|
artikel
|
| 33 |
Vitamin A deficiency—an unexpected cause of visual loss
|
Simkin, Samantha K
|
|
2016
|
387 |
10013 |
p. 93-94
2 p.
|
artikel
|
| 34 |
Vitamin A deficiency in adolescents: rare or underdiagnosed?
|
Couroucli, Xanthi I
|
|
2016
|
387 |
10013 |
p. 94-
1 p.
|
artikel
|
| 35 |
What does Pfizer's merger mean for drug development?
|
Mullard, Asher
|
|
2016
|
387 |
10013 |
p. 14-15
2 p.
|
artikel
|
Tijdschrift beschrijving